Current report No. 9/2021 – Resolutions adopted by the Extraordinary General Meeting of Celon Pharma S.A. on February 16, 2021

February 16, 2021

Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information
Content of the report:
Management Board of Celon Pharma S.A. (the “Company”) hereby publishes the text of the resolutions adopted by the Extraordinary General Meeting of the Company on February 16, 2021 along with appendices thereto.

Since the electronic vote-counting system was used, no resolution on the election of the Returning Committee has been adopted. No item on the agenda has been withdrawn and no objection to any of the adopted resolutions has been raised.

(Resolutions of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021)

(Appendix to the Resolution No. 4 of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021; Opinion of the Management Board)

(Appendix to Resolutions No. 6 and 7 of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021; Justification)

(Appendix to Resolutions No. 6 and 7 of the Extraordinary General Meeting of Celon Pharma S.A. held on February 16, 2021; Justification)